Oculodental syndrome, Rutherfurd type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2709OMIM:180900Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Oculodental syndrome, Rutherfurd type (also known as Rutherfurd syndrome) is an extremely rare genetic disorder characterized by the combination of ocular and dental abnormalities. The condition was first described in a large family by Rutherfurd in 1931. Key clinical features include corneal dystrophy (opacification of the cornea leading to progressive visual impairment), gingival hyperplasia (overgrowth of the gum tissue), and failure of tooth eruption, particularly affecting the permanent teeth. The dental abnormalities may include delayed or absent eruption of teeth, which can be embedded within the hyperplastic gingival tissue. The corneal changes typically manifest as a progressive corneal dystrophy that can impair vision over time. The syndrome primarily affects two body systems: the eyes and the oral/dental structures. Gingival fibromatosis (thickening and overgrowth of the gums) is a prominent feature and may require surgical intervention (gingivectomy) to allow tooth eruption or improve oral function. Corneal dystrophy may require ophthalmologic management, and in severe cases, corneal transplantation may be considered. There is no specific curative treatment for Rutherfurd syndrome; management is symptomatic and supportive, focusing on dental surgical procedures to address gingival overgrowth and ophthalmologic care for corneal involvement. Given the extreme rarity of this condition, clinical experience is limited and management is guided by individual patient needs.

Also known as:

Clinical phenotype terms— hover any for plain English:

Gingival fibromatosisHP:0000169Impaired masticationHP:0005216
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Oculodental syndrome, Rutherfurd type.

View clinical trials →

No actively recruiting trials found for Oculodental syndrome, Rutherfurd type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Oculodental syndrome, Rutherfurd type community →

No specialists are currently listed for Oculodental syndrome, Rutherfurd type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Oculodental syndrome, Rutherfurd type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Oculodental syndrome, Rutherfurd typeForum →

No community posts yet. Be the first to share your experience with Oculodental syndrome, Rutherfurd type.

Start the conversation →

Latest news about Oculodental syndrome, Rutherfurd type

No recent news articles for Oculodental syndrome, Rutherfurd type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Oculodental syndrome, Rutherfurd type

What is Oculodental syndrome, Rutherfurd type?

Oculodental syndrome, Rutherfurd type (also known as Rutherfurd syndrome) is an extremely rare genetic disorder characterized by the combination of ocular and dental abnormalities. The condition was first described in a large family by Rutherfurd in 1931. Key clinical features include corneal dystrophy (opacification of the cornea leading to progressive visual impairment), gingival hyperplasia (overgrowth of the gum tissue), and failure of tooth eruption, particularly affecting the permanent teeth. The dental abnormalities may include delayed or absent eruption of teeth, which can be embedded

How is Oculodental syndrome, Rutherfurd type inherited?

Oculodental syndrome, Rutherfurd type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Oculodental syndrome, Rutherfurd type typically begin?

Typical onset of Oculodental syndrome, Rutherfurd type is childhood. Age of onset can vary across affected individuals.